• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by Braskem SA ADR

    10/21/24 9:25:58 PM ET
    $BAK
    Major Chemicals
    Industrials
    Get the next $BAK alert in real time by email
    6-K 1 bak20241021_6k.htm 6-K

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     


     

    FORM 6-K

     

    REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16
    OR 15D-16 OF THE SECURITIES EXCHANGE ACT OF 1934


    For the month of October, 2024

    (Commission File No. 1-14862 )

     


     

    BRASKEM S.A.

    (Exact Name as Specified in its Charter)

     

    N/A

    (Translation of registrant's name into English)

     


     

    Rua Eteno, 1561, Polo Petroquimico de Camacari
    Camacari, Bahia - CEP 42810-000 Brazil

    (Address of principal executive offices)

     


     

    Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

    Form 20-F ___X___       Form 40-F ______

     

    Indicate by check mark if the registrant is submitting the Form 6-K
    in paper as permitted by Regulation S-T Rule 101(b)(1). _____

     

    Indicate by check mark if the registrant is submitting the Form 6-K
    in paper as permitted by Regulation S-T Rule 101(b)(7). _____

     

    Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

    Yes ______       No ___X___

    If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- _____.

     

     
     

     

     

    Braskem Netherlands Finance B.V. announces early results of cash tender offer for

    any and all of its outstanding Subordinated Resettable Fixed Rate Notes due 2081

    São Paulo, Brazil – October 21, 2024 – Braskem Netherlands Finance B.V. (“Braskem Netherlands Finance” or the “Offeror”) today announces the early results as of 5:00 p.m., New York City time, on October 21, 2024 (the “Early Tender Date”) of its previously announced offer to purchase for cash any and all of the outstanding Subordinated Resettable Fixed Rate Notes due 2081 (the “Notes”) issued by Braskem Netherlands Finance (the “Offer”). The Offer is being made upon the terms and subject to the conditions set forth in the previously announced offer to purchase dated October 7, 2024 (the “Offer to Purchase”).

    The Offeror has been advised by the information and tender agent that, as of the Early Tender Date, the amount of Notes set forth in the table below were validly tendered and not validly withdrawn. As set forth in the table below, the Notes validly tendered and not validly withdrawn as of the Early Tender Date will be accepted for purchase.

    The following table summarizes the early results of the Offer.

    Title of
    Security

    Security Identifiers

    Principal Amount
    Tendered and Accepted

    Early Tender Payment

    Tender Offer Consideration

    Total Consideration(1)

    Subordinated Resettable Fixed Rate Notes due 2081

    CUSIP: 10554T AF2 / N15516 AF9

    ISIN: US10554TAF21 / USN15516AF97

    US$368,564,000 US$50.00 US$966.25 US$1,016.25
     
    (1)The amount to be paid for each US$1,000 principal amount of Notes validly tendered at or prior to the Early Tender Date and accepted for purchase. The Total Consideration includes an early tender payment of US$50.00 for each US$1,000.00 principal amount of Notes due to holders of the Notes who validly tendered and did not validly withdraw Notes at or prior to the Early Tender Date. In addition, Accrued Interest will be paid in cash.

     

    Holders who validly tendered and did not validly withdraw their Notes at or prior to the Early Tender Date, in the manner described in the previously announced Offer to Purchase, will be eligible to receive the Total Consideration, which includes the Early Tender Payment, plus Accrued Interest.

    The Total Consideration for each US$1,000.00 principal amount of Notes validly tendered and not validly withdrawn at or prior to the Early Tender Date and accepted for purchase pursuant to the Offer will be US$1,016.25 (the “Total Consideration”), which includes the consideration of US$966.25 (the “Tender Offer Consideration”) and an early tender payment equal to US$50.00 (the “Early Tender Payment”).

    Holders whose Notes are accepted for payment as of the Early Tender Date pursuant to the Offer will be paid accrued and unpaid interest on the Notes (“Accrued Interest”) up to, but excluding, the Early Settlement Date. The Offeror will not pay Accrued Interest for any periods following the Early Settlement Date in respect of any Notes accepted in the Offer as of the Early Tender Date. Accrued Interest on Notes accepted in the Offer as of the Early Tender Date will cease to accrue on the Early Settlement Date. The Early Settlement Date will be October 22, 2024, or as promptly as practicable thereafter (the “Early Settlement Date”).

    Withdrawal rights with respect to tendered Notes terminated on the Early Tender Date. Accordingly, following the Early Tender Date, Notes validly tendered, including Notes tendered prior to the Early Tender Date and Notes tendered thereafter, may no longer be validly withdrawn except in certain limited circumstances where additional withdrawal rights are required by applicable law.

    The Offeror has retained Citigroup Global Markets Inc., Itau BBA USA Securities, Inc., Morgan Stanley & Co. LLC, Santander US Capital Markets LLC and SMBC Nikko Securities America, Inc. to serve as dealer managers and D.F. King & Co., Inc. to serve as information and tender agent for the Offer. The full details of the Offer, including complete instructions on how to tender Notes, are included in the previously announced Offer to Purchase. Holders of Notes are strongly encouraged to carefully read the previously announced Offer to Purchase, including materials incorporated by reference therein, because they contain important information. Requests for the previously announced Offer to Purchase and any related supplements may also be directed to D.F. King & Co., Inc. by telephone at +1 (212) 269-5550 or +1 (800) 207-3159 (US toll free) or in writing at [email protected].

     
     

    Questions about the Offer may be directed to Citigroup Global Markets Inc. by telephone at +1 (800) 558-3745 (toll free) or +1 (212) 723-6106 (collect); Itau BBA USA Securities, Inc. by telephone at +1 (888) 770-4828 (toll free) or +1 (212) 710-6749 (collect); Morgan Stanley & Co. LLC by telephone at +1 (800) 624-1808 (toll free) or +1 (212) 761-1057 (collect); Santander US Capital Markets LLC by telephone at +1 (855) 404-3636 (toll free) or +1 (212) 940-1442 (collect), or by e-mail at [email protected]; and SMBC Nikko Securities America, Inc. by telephone at +1 (888) 284-9760 (toll free) or +1 (212) 224-5163 (collect).

    This press release shall not constitute an offer to purchase or a solicitation of acceptance of the offer to purchase, which are being made only pursuant to the terms and conditions contained in the previously announced Offer to Purchase. The Offer is not being made to, nor will the Offeror accept tenders of Notes from, holders in any jurisdiction in which the Offer or the acceptance thereof would not be in compliance with the securities or blue sky laws of such jurisdiction. In any jurisdiction where the laws require the Offer to be made by a licensed broker or dealer, the Offer will be made by the dealer managers on behalf of the Offeror.

    None of the Offeror, the information and tender agent, the dealer managers or the trustee with respect to the Notes, nor any of their respective affiliates, makes any recommendation as to whether holders should tender or refrain from tendering all or any portion of their Notes in response to the Offer. None of the Offeror, the information and tender agent, the dealer managers or the trustee with respect to the Notes, nor any of their respective affiliates, has authorized any person to give any information or to make any representation in connection with the Offer other than the information and representations contained in the previously announced Offer to Purchase.

    Neither the U.S. Securities and Exchange Commission, any U.S. state securities commission nor any regulatory authority of any other country has approved or disapproved of the Offer, passed upon the merits or fairness of the Offer or passed upon the adequacy or accuracy of the disclosure in the previously announced Offer to Purchase.

    About Braskem Netherlands Finance

    Braskem Netherlands Finance, a private company with limited liability (besloten vennootschap met beperkte aansprakelijkheid) incorporated under the laws of the Netherlands, is a wholly-owned subsidiary of Braskem Netherlands B.V. Braskem Netherlands Finance was established primarily to act as a finance subsidiary of Braskem S.A.

    Forward-Looking Statements

    Statements in this press release may be “forward-looking statements” within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended, which are subject to risks and uncertainties. Other than statements of historical fact, information regarding activities, events and developments that Braskem expects or anticipates will or may occur in the future are forward-looking statements based on management’s estimates, assumptions and projections. Many forward-looking statements may be identified by the use of words such as “expect,” “anticipate,” “intend,” “plan,” “believe, “estimate” and similar expressions. Forward-looking statements contained in this press release are predictions only and actual results could differ materially from management’s expectations due to a variety of factors, including those described the sections titled “Risk Factors” in Braskem’s annual report on Form 20-F for the year ended December 31, 2023 and Braskem’s report on Form 6-K including certain information regarding Braskem and, without limitation, Braskem’s Management’s Discussion and Analysis of Financial Condition and Results of Operations for the six-month periods ended June 30, 2024 and 2023, furnished to the SEC on October 7, 2024. All forward-looking statements attributable to Braskem or the Offeror are expressly qualified in their entirety by such risk factors. The forward-looking statements that the Offeror makes in this press release are based on management’s current views and assumptions regarding future events and speak only as of their dates. The Offeror assumes no obligation to update developments of these risk factors or to announce publicly any revisions to any of the forward-looking statements that the Offeror makes, or to make corrections to reflect future events or developments, except as required by the U.S. federal securities laws.

     
    2 
     

    DISCLAIMER

    This press release must be read in conjunction with the previously announced Offer to Purchase. This announcement and the previously announced Offer to Purchase contain important information which must be read carefully before any decision is made with respect to the Offer. If any holder of Notes is in any doubt as to the action it should take, it is recommended to seek its own legal, tax, accounting and financial advice, including as to any tax consequences, immediately from its stockbroker, bank manager, attorney, accountant or other independent financial or legal adviser. Any individual or company whose Notes are held on its behalf by a broker, dealer, bank, custodian, trust company or other nominee or intermediary must contact such entity if it wishes to participate in the Offer. None of the Offeror, the dealer managers, the information and tender agent and any person who controls, or is a director, officer, employee or agent of such persons, or any affiliate of such persons, makes any recommendation as to whether holders of Notes should participate in the Offer.

     
    3 
     

    SIGNATURES

            Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

    Date: October 21, 2024

      BRASKEM S.A.
           
           
      By:      /s/     Pedro van Langendonck Teixeira de Freitas
         
        Name: Pedro van Langendonck Teixeira de Freitas
        Title: Chief Financial Officer

     

    DISCLAIMER ON FORWARD-LOOKING STATEMENTS

     

    This report on Form 6-K may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are statements that are not historical facts, and are based on our management’s current view and estimates of future economic and other circumstances, industry conditions, company performance and financial results, including any potential or projected impact of the geological event in Alagoas and related legal proceedings and of COVID-19 on our business, financial condition and operating results. The words “anticipates,” “believes,” “estimates,” “expects,” “plans” and similar expressions, as they relate to the company, are intended to identify forward-looking statements. Statements regarding the potential outcome of legal and administrative proceedings, the implementation of principal operating and financing strategies and capital expenditure plans, the direction of future operations and the factors or trends affecting our financial condition, liquidity or results of operations are examples of forward-looking statements. Such statements reflect the current views of our management and are subject to a number of risks and uncertainties, many of which are outside of the our control. There is no guarantee that the expected events, trends or results will actually occur. The statements are based on many assumptions and factors, including general economic and market conditions, industry conditions, and operating factors. Any changes in such assumptions or factors, including the projected impact of the geological event in Alagoas and related legal proceedings and the unprecedented impact of COVID-19 pandemic on our business, employees, service providers, stockholders, investors and other stakeholders, could cause actual results to differ materially from current expectations. Please refer to our annual report on Form 20-F for the year ended December 31, 2019 filed with the SEC, as well as any subsequent filings made by us pursuant to the Exchange Act, each of which is available on the SEC’s website (www.sec.gov), for a full discussion of the risks and other factors that may impact any forward-looking statements in this presentation.


     

     

     

    Get the next $BAK alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BAK

    DatePrice TargetRatingAnalyst
    9/26/2025$3.80Buy → Neutral
    UBS
    3/3/2025Sector Outperform → Sector Perform
    Scotiabank
    9/18/2024Neutral → Buy
    UBS
    8/20/2024Neutral → Buy
    Citigroup
    8/29/2023Neutral → Sell
    UBS
    7/5/2023$11.50 → $11.00Overweight → Neutral
    JP Morgan
    6/14/2023Hold → Buy
    HSBC Securities
    5/18/2023Buy → Neutral
    UBS
    More analyst ratings

    $BAK
    SEC Filings

    View All

    SEC Form 6-K filed by Braskem SA ADR

    6-K - BRASKEM SA (0001071438) (Filer)

    2/9/26 5:21:29 PM ET
    $BAK
    Major Chemicals
    Industrials

    SEC Form 6-K filed by Braskem SA ADR

    6-K - BRASKEM SA (0001071438) (Filer)

    2/9/26 4:12:36 PM ET
    $BAK
    Major Chemicals
    Industrials

    SEC Form 6-K filed by Braskem SA ADR

    6-K - BRASKEM SA (0001071438) (Filer)

    2/9/26 4:10:18 PM ET
    $BAK
    Major Chemicals
    Industrials

    $BAK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    From Air to Plastics: Norsk e-Fuel and Braskem Partner to Turn Captured Carbon into Long-Lasting Products

    Norsk e-Fuel AS, a pioneer in Power-to-Liquid (PtL) technology, and Braskem, a global leader in polymers and biopolymers, have announced a strategic collaboration to explore the possible integration of e-Naphtha into the plastics value chain. This partnership aims to accelerate the development of plastics derived from carbon that would otherwise be released into the atmosphere, reinforcing both companies' commitment to a circular future. Norsk e-Fuel is driving the industrial rollout of PtL technology by building large-scale facilities that convert fossil-free electricity, water, and captured CO₂ into synthetic fuels and feedstocks. The company's plan foresees at least three plants in ope

    11/20/25 4:00:00 AM ET
    $BAK
    Major Chemicals
    Industrials

    With Braskem's I'm green™ bio-based Polyethylene, Balsam Hill Made the World's First Plant-Based Plastic Christmas Trees

    Braskem (B3: BRKM3, BRKM5, and BRKM6, NYSE:BAK, LATIBEX: XBRK), the largest polyolefins producer in the Americas and global leader in the production of biopolymers on an industrial scale, and Balsam Hill®, the global leader in high-quality, true-to-nature, reusable artificial Christmas trees and holiday décor, are excited to introduce the world's first Christmas trees made with plant-based plastic. For Balsam Hill, these trees are an important part of the company's reNEW™ commitment to move towards new and more sustainable materials (recycled or renewable), starting with trees. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/202510

    10/27/25 8:00:00 AM ET
    $BAK
    Major Chemicals
    Industrials

    Braskem Unveils Bio-based Product Innovations at K 2025

    Braskem, a market leader in the production of biopolymers on an industrial scale, is currently at K 2025, the world's leading trade fair for plastics and rubber in Düsseldorf, Germany. On the opening day, Braskem showcased a new generation of bio-based and circular product solutions aimed at accelerating the transformation of the plastics industry. Under its sustainable portfolio, Braskem is revealing product launches and partnerships that bring sustainability and innovation to life across packaging, healthcare, hygiene, and consumer goods. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251009859755/en/I'm green bio-based polyet

    10/9/25 4:00:00 AM ET
    $BAK
    Major Chemicals
    Industrials

    $BAK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Braskem SA downgraded by UBS with a new price target

    UBS downgraded Braskem SA from Buy to Neutral and set a new price target of $3.80

    9/26/25 8:01:31 AM ET
    $BAK
    Major Chemicals
    Industrials

    Braskem SA downgraded by Scotiabank

    Scotiabank downgraded Braskem SA from Sector Outperform to Sector Perform

    3/3/25 7:16:10 AM ET
    $BAK
    Major Chemicals
    Industrials

    Braskem SA upgraded by UBS

    UBS upgraded Braskem SA from Neutral to Buy

    9/18/24 7:29:50 AM ET
    $BAK
    Major Chemicals
    Industrials

    $BAK
    Leadership Updates

    Live Leadership Updates

    View All

    Empowering Brands with Bio-Based Innovation: Braskem Highlights I'm green™ bio-based Portfolio at Sustainable Brands

    I'm green™ bio-based will highlight its collaboration with forward-thinking brands to scale bio-based solutions globally Braskem's I'm green™ bio-based brand will participate in Sustainable Brands 2025, held in San Diego, Calif., from Oct. 13 to 16 to raise awareness about carbon footprint and its impact on climate change. Backed by more than 200 Life Cycle Assessments (LCAs) data, the company will engage in discussions and showcase how replacing traditional fossil-based materials with bio-based alternatives can significantly reduce carbon emissions and support the transition to a low-carbon circular economy. Attendees can explore I'm green™ bio-based at its booth, in program sessions,

    10/6/25 10:33:00 AM ET
    $BAK
    Major Chemicals
    Industrials

    $BAK
    Financials

    Live finance-specific insights

    View All

    Braskem and Oxiteno sign a partnership to supply bio-attributed ethylene

    Oxiteno will receive Braskem's certified raw material for the production of new sustainable solutions, providing a breakthrough in the Brazilian chemical industry. Committed to supporting the circular economy and fighting climate change, Brazilian petrochemical companies Braskem and Indorama Ventures IOD - Oxiteno announce a partnership to supply bio-attributed ethylene from renewable sources. Bio-attributed ethylene, certified by ISCC (International Sustainability and Carbon Certification), will be used by Oxiteno to create new sustainable solutions. This raw material is the first bio-attributed chemical product produced by Braskem from the certified mass balance approach. The concep

    11/6/23 8:00:00 AM ET
    $BAK
    Major Chemicals
    Industrials

    Origin Materials, Inc. Reports Operating and Financial Results for Second Quarter 2023

    – Origin 1 Initiated Start-Up, In-Line with Prior Guidance – – FDCA Mass Production Moves Forward to Origin 2, Rather Than Origin 3 as Initially Planned, Due to Strong Commercialization Progress and Higher-Margin Opportunities – – Origin 2 Outlook Updated; Phased Construction Plan Reduces Risk on Path to Profitability, with Phase 1 Start-Up Expected in Late 2026 to 2027, Phase 2 Start-Up Expected in 2028 – – Origin to Supply Para-Xylene for Bio-PET to Customers Prior to 2030 Primarily Through Collaborations with Strategic Partners – – Maintains 2023 Revenue and Adjusted EBITDA Outlook, Customer Demand Exceeds $10 Billion – Origin Materials, Inc. ("Origin," "Origin Materials," or t

    8/9/23 4:01:00 PM ET
    $BAK
    $ORGN
    Major Chemicals
    Industrials

    Braskem Acquires taulman3D Expanding its Portfolio of Materials for Additive Manufacturing Applications

    The acquisition of taulman3D further accelerates Braskem's growth strategy in the additive manufacturing market with a highly complementary portfolio of 3D materials trusted by professionals worldwide. taulman3D filaments and polymers are available globally, through distributors on 6 continents Braskem ((B3: BRKM3, BRKM5, and BRKM6, NYSE:BAK, LATIBEX: XBRK)) the largest polyolefins producer in the Americas, as well as a market leader and pioneer producer of biopolymers on an industrial scale, today announced the acquisition of taulman3D, a leading 3D filament supplier of nylon, recycled PETG, and PET filaments to aerospace, automotive, healthcare, industrial, government and higher educati

    1/4/23 8:00:00 AM ET
    $BAK
    Major Chemicals
    Industrials